How does hypervolemia increase the mortality risk in sepsis?
16 Jan 2025
This session, from the 2024 World Sepsis Congress Spotlight: Unmet Need in Sepsis Diagnosis and Therapy, explores how hypervolemia can impact sepsis and includes discussions on how to diagnose and manage hypervolemia in cases of sepsis, how and when to remove fluid, and whether the early use of vasopressors can reduce cases of hypervolemia.
Time stamps for easy viewing:
00:00 Introduction
00:01:00 Manu Malbrain, International Fluid Academy, Poland – Desired and Undesired Effects of Fluids
00:14:13 Sheila Myatra, Asia Pacific Sepsis Alliance, India – Diagnosis and Management of Hypervolemia in Sepsis
00:31:20 Jean-Louis Teboul, University Paris-S aclay France – Can Early Use of Vasopressors Avoid Hypervolemia? 00:47:47 Ludhmila Hajjar, University of Sao Paulo, Brazil – The Safety Limits to Stop Fluid Infusions
01:03:53 Marlies Ostermann, Guy's and St Thomas' NHS Foundation Trust, UK – Fluid Removal: When and How?
About the company
Global Sepsis Alliance
The Global Sepsis Alliance (GSA) is a non-profit charity organization with the mission to provide global leadership to reduce the worldwide burden of sepsis. The GSA is the initiator of World Sepsis Day on September 13 and World Sepsis Congress, a series of free online congresses bringing knowledge about sepsis to all parts of the world, among other initiatives.
The GSA works closely with its over 120 member organizations from all over the world – patient advocacy groups, professional societies, healthcare authorities, and governments – to implement changes on how sepsis is prioritized, diagnosed, and treated all around the world, as laid out in the WHO Resolution on Sepsis.
